Part 4: The Cholinergic Toxidrome

Section 11: Management of the Cholinergic Toxidrome Management Strategy 2: Supportive Care

Course: WB 1098
CE Original Date: October 16, 2007
CE Renewal Date: October 16, 2010
CE Expiration Date: October 16, 2012
Download Printer-Friendly Version pdf icon[PDF – 1.88MB]

Learning Objectives

Upon completion of this section, you should be able to

  • Identify the most important organ system requiring supportive care in patients suffering from the cholinergic toxidrome.
Introduction

Monitoring and intensive supportive care are critical components of patient management in severe poisoning cases. Monitoring of exposed patients may need to be prolonged because of the possibility of delayed onset of effects from cholinesterase inhibitors.

Importance of Respiratory Support

Death from cholinesterase inhibitor poisoning is usually due to respiratory failure from a combination of: (Zwiener and Ginsburg 1988; Sofer, Tal et al. 1989; Reigart and Roberts 1999)

  • Bronchoconstriction.
  • Bronchorrhea.
  • Central respiratory depression.
  • Weakness or paralysis of respiratory muscles.

Therefore, early, aggressive respiratory support is a mainstay of treatment, including endotracheal intubation and mechanical ventilation when indicated.

Key Points
  • Supportive care plays a critical role in the medical management of the cholinergic toxidrome.
  • Aggressive respiratory support is particularly important, since respiratory failure is the usual cause of fatality.
Page last reviewed: October 16, 2007